Loading insider details...
Beta
Latest Form 4 (Apr 1, 2026): Purchase of 30,978 APRE shares, $25.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 1, 2026 | Aprea Therapeutics, Inc. (APRE) | Purchase | 30,978 | $25.0K |
| Mar 16, 2026 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 10,095 | n/a |
| Feb 2, 2026 | Aprea Therapeutics, Inc. (APRE) | Purchase | 5,700 | $5.1K |
| Dec 11, 2025 | Aprea Therapeutics, Inc. (APRE) | Purchase | 5,000 | $5.8K |
| Mar 31, 2025 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 3,365 | n/a |
| Oct 16, 2024 | Aprea Therapeutics, Inc. (APRE) | Purchase | 50 | $123.19 |
| Oct 15, 2024 | Aprea Therapeutics, Inc. (APRE) | Purchase | 450 | $1.2K |
| Mar 28, 2024 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 3,365 | n/a |
| Mar 15, 2024 | Aprea Therapeutics, Inc. (APRE) | Purchase | 1,010 | $7.4K |
| Feb 27, 2023 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 1,000 | $5.3K |